https://theannexure.com/ Material BSE disclosures from the Pharmaceuticals & Biotechnology industry. en-in 2026-08-26 18:48 UTC https://theannexure.com/company/544319.html#f/c592919fed6f annexure:c592919fed6f Change in Management Wed, 26 Aug 2026 19:01:39 +0530 Senores Pharmaceuticals Limited has informed the Exchange regarding Appointment of Independent Director https://theannexure.com/company/544319.html#f/e56a9ff4fc27 annexure:e56a9ff4fc27 KMP Wed, 26 Aug 2026 18:59:15 +0530 Senores Pharmaceuticals Limited has informed the Exchange regarding appointment of Company Secretary and Compliance Officer of the Company https://theannexure.com/company/544319.html#f/2fc06703a17a annexure:2fc06703a17a Acquisition Wed, 26 Aug 2026 18:57:43 +0530 Senores Pharmaceuticals Limited has informed the Exchange regarding proposed incorporation of Subsidiary Company in Canada https://theannexure.com/company/544319.html#f/1e93609cf733 annexure:1e93609cf733 Acquisition Wed, 26 Aug 2026 18:56:17 +0530 Senores Pharmaceuticals Limited has informed the Exchange regarding proposed incorporation of Wholly owned subsidiary in Mexico https://theannexure.com/company/543904.html#f/ded2c7e9fec9 annexure:ded2c7e9fec9 Restructuring Wed, 26 Aug 2026 16:43:03 +0530 Please find attached outcome of the Board Meeting held today, according consent of the Board of Directors of the Company for the integration of Bharat Serums and Vaccines Limited, a wholly .... https://theannexure.com/company/524735.html#f/c1e1799f9c86 annexure:c1e1799f9c86 Change in Management Wed, 26 Aug 2026 13:30:11 +0530 Please find attached intimation on appointment of Chairman and Managing Director of the Company, subject to approval of shareholders at ensuing AGM of the Company. https://theannexure.com/company/506820.html#f/b59d2baff71c annexure:b59d2baff71c Order / Contract Tue, 25 Aug 2026 21:16:04 +0530 Please find the enclosed document of the Company in relation to the captioned subject for your reference. https://theannexure.com/company/524558.html#f/31d6787bd548 annexure:31d6787bd548 Credit Rating Tue, 25 Aug 2026 20:39:37 +0530 Announcement under Regulation 30 (LODR) - Credit Rating https://theannexure.com/company/543298.html#f/321f6206f309 annexure:321f6206f309 Results Tue, 25 Aug 2026 19:28:44 +0530 The Board of Director of the company in its meeting held on August 25 2026 Approved the Audited Standalone Financial Results for the fourth quarter and the financial year ended on 31st .... https://theannexure.com/company/543298.html#f/621872e183a7 annexure:621872e183a7 Board Outcome Tue, 25 Aug 2026 19:12:35 +0530 The Board of Directors of the company in its meeting held today i.e., on August 25, 2026 has: Approved the Audited Standalone Financial Results of the Company for the fourth quarter and .... https://theannexure.com/company/544742.html#f/152b6b7ad937 annexure:152b6b7ad937 Press Release Tue, 25 Aug 2026 18:38:54 +0530 Announcement under Regulation 30 (LODR) https://theannexure.com/company/544742.html#f/4c7c48f68e72 annexure:4c7c48f68e72 Order / Contract Tue, 25 Aug 2026 18:36:22 +0530 Announcement under Regulation 30 (LODR) https://theannexure.com/company/540025.html#f/4cafe277b638 annexure:4cafe277b638 Buyback Tue, 25 Aug 2026 18:21:35 +0530 Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 25, 2026. https://theannexure.com/company/524202.html#f/88b9c239c200 annexure:88b9c239c200 Change in Management Tue, 25 Aug 2026 18:15:30 +0530 Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 we hereby submit the disclosure towards the Appointment of Internal Auditor And Cost Auditor. https://theannexure.com/company/524516.html#f/5ef01e766a93 annexure:5ef01e766a93 Board Outcome Tue, 25 Aug 2026 16:50:13 +0530 Outcome of Board Meeting held on 25th August, 2026 https://theannexure.com/company/540702.html#f/b27efdbd747e annexure:b27efdbd747e KMP Tue, 25 Aug 2026 16:14:40 +0530 Resignation of Mr. Ganesh Potdar executive director as on 25-08-2026 https://theannexure.com/company/524816.html#f/71253558b602 annexure:71253558b602 Press Release Tue, 25 Aug 2026 12:22:33 +0530 Press Release & Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding the investment in eGenesis, Inc. https://theannexure.com/company/524238.html#f/6c6a864c5fb2 annexure:6c6a864c5fb2 Press Release Tue, 25 Aug 2026 08:16:50 +0530 Press note/Media Released Q2 2026-2027 https://theannexure.com/company/524372.html#f/d579bc79f58e annexure:d579bc79f58e Concall Transcript Mon, 24 Aug 2026 18:19:14 +0530 Transcript of Analysts/Investors earning call held with public at large on August 21, 2026. https://theannexure.com/company/540025.html#f/c48433d6e07b annexure:c48433d6e07b Buyback Mon, 24 Aug 2026 18:01:01 +0530 Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 24, 2026. https://theannexure.com/company/544529.html#f/4f93ce00cb51 annexure:4f93ce00cb51 Press Release Mon, 24 Aug 2026 13:34:55 +0530 Aptus Pharma Limited - Press release regarding - Aptus Pharma Limited charts next growth phase with focus on manufacturing, pan-India expansion and global markets https://theannexure.com/company/524238.html#f/1f0d0c1a2225 annexure:1f0d0c1a2225 Contract / MoU Mon, 24 Aug 2026 12:46:02 +0530 Announcement regarding enter into Strategic Business Partnership Agreement https://theannexure.com/company/544529.html#f/fc5fb9b40406 annexure:fc5fb9b40406 Investor Presentation Fri, 21 Aug 2026 19:47:04 +0530 Intimation of investor presentation under regulation 30 of SEBI (LODR) Regulations, 2015 https://theannexure.com/company/514336.html#f/c1622d309463 annexure:c1622d309463 Change in Management Fri, 21 Aug 2026 18:23:13 +0530 Intimation for appointment of INED cum Chairperson and change in designation. Also reconstitution of committees. https://theannexure.com/company/524314.html#f/c2e0a6c8291f annexure:c2e0a6c8291f Change in Directorate Fri, 21 Aug 2026 16:12:12 +0530 Detailed disclosure is attached. https://theannexure.com/company/524314.html#f/06410e5f301f annexure:06410e5f301f Change in Directorate Fri, 21 Aug 2026 16:04:35 +0530 Corrigendum/Revised intimation regarding Re-appointment of Managing Director & Chief Executive Officer of the Company- Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) .... https://theannexure.com/company/532321.html#f/3cbbbd980153 annexure:3cbbbd980153 Press Release Fri, 21 Aug 2026 13:55:08 +0530 Zydus announces final approval from the USFDA for Ascorbic Acid Injection with 180-Days CGT exclusivity. https://theannexure.com/company/540025.html#f/67d4025a256f annexure:67d4025a256f Buyback Fri, 21 Aug 2026 17:48:54 +0530 Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 21, 2026. https://theannexure.com/company/540701.html#f/1bf3a3156531 annexure:1bf3a3156531 Concall Transcript Fri, 21 Aug 2026 17:28:30 +0530 Please find enclosed herewith transcript of conference call held on 17th August, 2026. https://theannexure.com/company/524816.html#f/8f4e27238df1 annexure:8f4e27238df1 Press Release Fri, 21 Aug 2026 17:27:57 +0530 Conclusion of US FDS Inspection at our Visakhapatnam, Andhra Pradesh, Finished Dosage (FDF) Unit https://theannexure.com/company/509079.html#f/37fe8a086bc0 annexure:37fe8a086bc0 Concall Transcript Fri, 21 Aug 2026 17:14:49 +0530 Written Transcript of Earnings Conference Call held on August 17, 2026 at 04:30 p.m. is attached herewith https://theannexure.com/company/524546.html#f/4a62728f2267 annexure:4a62728f2267 CIRP Fri, 21 Aug 2026 15:27:43 +0530 Admission of Application by NCLT and Appointment of IRP. https://theannexure.com/company/538964.html#f/907895bf5084 annexure:907895bf5084 Change in Management Fri, 21 Aug 2026 14:32:10 +0530 Intimation regarding appointment of Mr. Sunil Sharma and resignation of Ms. Seema Salvi as HOD injectable https://theannexure.com/company/532296.html#f/0352b166d000 annexure:0352b166d000 Press Release Fri, 21 Aug 2026 08:52:23 +0530 Glenmark Pharmaceuticals Inc., USA launches Calcium Gluconate Injection USP, 1,000 mg/10 mL (100 mg/mL), 5,000 mg/50 mL (100 mg/mL) Single-Dose Vials and 10,000 mg/100 mL (100 mg/mL) Pharmacy .... https://theannexure.com/company/524202.html#f/3de3bfbd460a annexure:3de3bfbd460a Scheme of Arrangement Thu, 20 Aug 2026 19:27:40 +0530 Scheme of Amalgamation has been sanctioned by Hon'ble NCLT Ahmedabad Bench. The Certified True copy of the NCLT order has been received by the Company on 20th August 2026. https://theannexure.com/company/533573.html#f/06350241810c annexure:06350241810c KMP Thu, 20 Aug 2026 19:01:35 +0530 Intimation regarding Appointment of Company Secretary of the Company. https://theannexure.com/company/524372.html#f/369edc547f4f annexure:369edc547f4f Investor Presentation Thu, 20 Aug 2026 18:09:43 +0530 Investors Presentation-Quarter 1 of F.Y.2026-27, ended on June 30, 2026. https://theannexure.com/company/540025.html#f/f5c1323acbfc annexure:f5c1323acbfc Buyback Thu, 20 Aug 2026 18:09:40 +0530 Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 20, 2026 https://theannexure.com/company/539523.html#f/20871644d69a annexure:20871644d69a Concall Transcript Thu, 20 Aug 2026 18:01:51 +0530 Please find attached herewith Q1 FY27- Earnings Call Transcript. https://theannexure.com/company/539523.html#f/b3e5072192f3 annexure:b3e5072192f3 Concall Transcript Thu, 20 Aug 2026 18:00:33 +0530 Please find attached herewith Q1 FY27- Earnings Call Transcript. https://theannexure.com/company/532305.html#f/c1022708f3fc annexure:c1022708f3fc Concall Transcript Thu, 20 Aug 2026 17:55:31 +0530 Please find enclosed Transcript of Earning Call held on August 17, 2026. https://theannexure.com/company/543389.html#f/b07dc14846ea annexure:b07dc14846ea Concall Transcript Thu, 20 Aug 2026 17:48:26 +0530 Transcript of earnings call https://theannexure.com/company/526953.html#f/94257b0e55b2 annexure:94257b0e55b2 Change in Management Thu, 20 Aug 2026 17:35:53 +0530 As per the file enclosed. https://theannexure.com/company/524164.html#f/603118aafe68 annexure:603118aafe68 Concall Transcript Thu, 20 Aug 2026 16:29:18 +0530 Earning Call Transcript https://theannexure.com/company/543904.html#f/f5e36898c506 annexure:f5e36898c506 Press Release Thu, 20 Aug 2026 13:35:29 +0530 Please find attached press release dated August 20, 2026. https://theannexure.com/company/524404.html#f/dc1dfb9243b9 annexure:dc1dfb9243b9 Concall Transcript Thu, 20 Aug 2026 11:42:38 +0530 Transcript of Investors/Analyst meet on Q1 FY 27 Financial Results https://theannexure.com/company/532296.html#f/0191fe5d1d05 annexure:0191fe5d1d05 Press Release Thu, 20 Aug 2026 08:53:21 +0530 Glenmark Pharmaceuticals receives U.S. FDA approval for Fluticasone Propionate Nasal Spray, 0.05 mg (50 mcg)/spray